1. Dual Functional Eudragit ® S100/L30D-55 and PLGA Colon-Targeted Nanoparticles of Iridoid Glycoside for Improved Treatment of Induced Ulcerative Colitis.
- Author
-
Gao C, Yu S, Zhang X, Dang Y, Han DD, Liu X, Han J, and Hui M
- Subjects
- Animals, Apoptosis drug effects, Body Weight drug effects, Colitis, Ulcerative chemically induced, Colitis, Ulcerative genetics, Colitis, Ulcerative pathology, Colon drug effects, Cyclooxygenase 2 genetics, Cyclooxygenase 2 metabolism, Dextran Sulfate, Drug Liberation, Fluorescence, Hydrogen-Ion Concentration, Iridoid Glycosides blood, Iridoid Glycosides pharmacokinetics, Iridoid Glycosides pharmacology, Male, Matrix Metalloproteinase 9 genetics, Matrix Metalloproteinase 9 metabolism, Mice, Inbred ICR, NADPH Oxidases metabolism, Nanoparticles ultrastructure, Particle Size, RNA, Messenger genetics, RNA, Messenger metabolism, Rats, Sprague-Dawley, Tissue Distribution drug effects, Mice, Rats, Colitis, Ulcerative drug therapy, Colon pathology, Iridoid Glycosides therapeutic use, Nanoparticles chemistry, Polylactic Acid-Polyglycolic Acid Copolymer chemistry, Polymethacrylic Acids chemistry
- Abstract
Aim: Iridoid glycosides (IG) as the major active fraction of Syringa oblata Lindl. has a proven anti-inflammatory effect for ulcerative colitis (UC). However, its current commercial formulations are hampered by low bioavailability and unable to reach inflamed colon. To overcome the limitation, dual functional IG-loaded nanoparticles (DFNPs) were prepared to increase the residence time of IG in colon. The protective mechanism of DFNPs on DSS-induced colonic injury was evaluated in rats., Materials and Methods: We prepared DFNPs using the oil-in-water emulsion method. PLGA was selected as sustained-release polymer, and ES100 and EL30D-55 as pH-responsive polymers. The morphology and size distribution of NPs were measured by SEM and DLS technique. To evaluate colon targeting of DFNPs, DiR, was encapsulated as a fluorescent probe into NPs. Fluorescent distribution of NPs were investigated. The therapeutic potential and in vivo transportation of NPs in gastrointestinal tract were evaluated in a colitis model., Results: SEM images and zeta data indicated the successful preparation of DFNPs. This formulation exhibited high loading capacity. Drug release results suggested DFNPs released less than 20% at the first 6 h in simulated gastric fluid (pH1.2) and simulated small intestine fluid (pH6.8). A high amount of 84.7% sustained release from NPs in simulated colonic fluid (pH7.4) was beyond 24 h. DiR-loaded NPs demonstrated a much higher colon accumulation, suggesting effective targeting due to functionalization with pH and time-dependent polymers. DFNPs could significantly ameliorate the colonic damage by reducing DAI, macroscopic score, histological damage and cell apoptosis. Our results also proved that the potent anti-inflammatory effect of DFNPs is contributed by decrease of NADPH, gene expression of COX-2 and MMP-9 and the production of TNF-α, IL-17, IL-23 and PGE2., Conclusion: We confirm that DFNPs exert protective effects through inhibiting the inflammatory response, which could be developed as a potential colon-targeted system., Competing Interests: The authors report no conflicts of interest for this work., (© 2021 Gao et al.)
- Published
- 2021
- Full Text
- View/download PDF